Humanigen Inc (fka HGENQ)

[cowtown jay]

I'm trying to get an understanding of the vaccine compound we are incorporating into an expanded use of lenz for covid.

"It remains to be seen if the vaccine, anti-viral, and polyclonal antibodies that Humanigen wants to administer are proprietary formulations to the company, or are already commercialized."

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170563136&txt2find=vaccine

"I wonder if we will see a business partnership announced with Novavax and/or J&J."

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170285229&txt2find=novavax+vaccine

"So I have done some additional research, and I have concluded that our second drug compound, with the vaccine component, may not be intended for patients with covid after all. Rather, I think this second drug may be intended as a postexposure prophylaxis (PEP), especially for vulnerable patients domiciled with infected members of the household."

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170571146&txt2find=vaccine

When I saw that, "Evusheld contains polysorbate 80, which is in the Janssen COVID-19 Vaccine...," I wanted to know if that ingredient was also in the Novavax vaccine.

bottom of pg 3:

https://www.fda.gov/media/154703/download

If Humanigen is targeting the post-exposure prophylaxis market, that could greatly expand the size of our treatment market, and I'm just trying to develop a feel for that potential.